CN112645887A - Preparation method of quinazolinone derivative - Google Patents

Preparation method of quinazolinone derivative Download PDF

Info

Publication number
CN112645887A
CN112645887A CN202011521464.9A CN202011521464A CN112645887A CN 112645887 A CN112645887 A CN 112645887A CN 202011521464 A CN202011521464 A CN 202011521464A CN 112645887 A CN112645887 A CN 112645887A
Authority
CN
China
Prior art keywords
solvent
producing
derivative according
quinazolinone
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202011521464.9A
Other languages
Chinese (zh)
Other versions
CN112645887B (en
Inventor
胡永珂
李华举
李少中
李彦兴
李进
周峰
端木传嵩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huaiyin Institute of Technology
Original Assignee
Huaiyin Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huaiyin Institute of Technology filed Critical Huaiyin Institute of Technology
Priority to CN202011521464.9A priority Critical patent/CN112645887B/en
Publication of CN112645887A publication Critical patent/CN112645887A/en
Application granted granted Critical
Publication of CN112645887B publication Critical patent/CN112645887B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/90Oxygen atoms with acyclic radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention discloses a preparation method of a quinazolinone derivative, which comprises the following steps: dissolving the o-aminobenzonitrile compounds shown in the formula I and aldehydes shown in the formula II in a solvent, and heating to react under the combined action of a catalyst, a ligand and alkali to generate quinazoline-4 (3) shown in the formula IIIH) A ketone derivative, after the reaction is finished, quinazoline-4 (3) is obtained by separationH) A crude product of the ketone derivative, which is purified to obtain quinazoline-4 (3)H) -pure ketone derivative; according to the invention, o-aminobenzonitrile and aldehyde which are easily obtained are used as starting materials, under the combined action of copper chloride and cesium carbonate, the o-aminobenzonitrile is hydrolyzed in situ to generate o-aminobenzamide, and then the o-aminobenzamide reacts with the aldehyde, so that the quinazolinone derivative is obtained by a one-pot method, and the reaction takes water as a solvent, so that the method is green and environment-friendly and has wide application prospects.

Description

Preparation method of quinazolinone derivative
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly relates to a preparation method of a quinazolinone derivative.
Background
Quinazolinone is a nitrogen-containing heterocyclic compound with good biological medical activity, and most of important natural alkaloids and synthetic drugs contain quinazolinone skeleton structures. Due to the wide pharmacological activity of the quinazolinone compound, the quinazolinone compound shows good activity in the aspects of antianaphylaxis, anticancer, antitumor, anti-inflammation, antihypertensive, insecticidal sterilization and the like. Therefore, the synthesis method has been receiving a lot of attention, and in recent years, different synthesis methods have been reported in succession, but most of them use aldehydes, acid anhydrides, acid chlorides, amidines, etc. and anthranilamides as raw materials, and these conventional synthesis methods have some disadvantages such as low yield, difficulty in obtaining raw materials, and use of equivalent or excessive amounts of oxidizing agents such as: KMnO4, MnO2, DDQ, t-BuOOH, PhI (OAo)2, etc., produce a large amount of by-products and severely pollute the environment (Eur.J.Med.chem.,2010,45, 4904-.
Disclosure of Invention
In view of the defects of the prior art, the invention aims to provide a preparation method of a quinazolinone derivative. The method takes aldehyde and o-aminobenzonitrile as initial raw materials, takes green water as a solvent, has mild reaction conditions, simple post-treatment and higher yield, and realizes the preparation of the quinazolinone derivative by a one-pot method.
The invention is realized by the following technical scheme:
a method for preparing a quinazolinone derivative, comprising the steps of:
dissolving an anthranilic nitrile compound shown in a formula I and an aldehyde shown in a formula II in a solvent, heating to react under the combined action of a catalyst, a ligand and alkali to generate a quinazoline-4 (3H) -ketone derivative shown in a formula III, separating after the reaction is finished to obtain a crude product of the quinazoline-4 (3H) -ketone derivative, and purifying the crude product to obtain a pure product of the quinazoline-4 (3H) -ketone derivative;
Figure BDA0002849095550000011
wherein R is1Is hydrogen, methyl, methoxy, halogen or nitro; r2Is C3-C8Alkyl, benzyl, phenyl, methylphenyl, methoxyphenyl, halophenyl, trifluoromethylphenyl, nitrophenyl, mercaptophenyl, cinnamyl, naphthyl, thienyl, furyl or pyridyl.
The invention further improves the scheme as follows:
the catalyst is CuXnWherein X is Cl, Br, I, OAc, OTf or SO4And n is 1 or 2.
Preferably, the catalyst is CuCl2
Further, the ligand is one or a mixture of more than two of 2,2' -bipyridyl, 4' -dimethyl-2, 2' -bipyridyl, triphenylphosphine, tricyclohexylphosphine, triphenylphosphine, 2, 9-dimethyl-1, 10-phenanthroline and 1, 10-phenanthroline.
Preferably, the ligand is 1, 10-phenanthroline.
Further, the alkali is one or more of potassium hydroxide, sodium hydroxide, potassium tert-butoxide, potassium methoxide, sodium bicarbonate, potassium carbonate or cesium carbonate.
Preferably, the base is cesium carbonate.
Furthermore, the solvent is one or more than two of toluene, dimethyl sulfoxide DMSO, DMF, tert-butyl alcohol, water or 1, 4-dioxane.
Preferably, the solvent is water.
Further, the reaction temperature is 60-80 ℃, the reaction time is 10-12 h, and in the reaction process, the thin-layer chromatography is used for tracking the reaction until the raw materials disappear, namely the reaction is finished; the separation process comprises the steps of cooling the reaction liquid to room temperature, filtering, washing a filter cake and drying; the purification method is column chromatography or recrystallization.
Further, the solvent of the column chromatography is petroleum ether/ethyl acetate with the volume ratio of 3:1, and the solvent of the recrystallization is methanol.
Further, the molar ratio of the o-aminobenzonitrile compound to the aldehyde to the catalyst to the ligand to the base is 1: 1-1.5: 0.08-0.12: 0.8-1.2.
Compared with the prior art, the invention has the beneficial effects that:
according to the invention, o-aminobenzonitrile and aldehyde which are easily obtained are used as starting materials, under the combined action of copper chloride and cesium carbonate, the o-aminobenzonitrile is hydrolyzed in situ to generate o-aminobenzamide, and then the o-aminobenzamide reacts with the aldehyde, so that the quinazolinone derivative is obtained by a one-pot method, and the reaction takes water as a solvent, so that the method is green and environment-friendly and has wide application prospects.
Detailed Description
Example 1: 2-phenylquinazolin-4 (3H) -ones
Figure BDA0002849095550000021
Anthranilic acid nitrile (1mmol), benzaldehyde (1.2mmol), CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 92%.
1H NMR(500MHz,DMSO-d6):δ=12.57(br s,1H),8.21–8.17(m,3H),7.85(t,J=7.6Hz,1H),7.76(d,J=8.0Hz,1H),7.62–7.52(m,4H);13C NMR(125MHz,DMSO-d6):δ162.4,152.4,148.9,134.7,132.9,131.5,128.7,127.9,127.6,126.7,126.0,121.1.
Example 2: 2-p-methylphenyl quinazolin-4 (3H) -one
Figure BDA0002849095550000031
Anthranilic acid nitrile (1mmol), 4-methylbenzaldehyde (1.2mmol), CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 95%.
1H NMR(500MHz,DMSO-d6):δ=12.48(br s,1H),8.16(d,J=7.8Hz,1H),8.11(d,J=8.2Hz,2H),7.87–7.80(m,1H),7.74(d,J=8.0Hz,1H),7.52(t,J=7.4Hz,1H),7.36(d,J=8.1Hz,2H),2.40(s,3H);13C NMR(125MHz,DMSO-d6):δ=162.4,152.4,149.0,141.6,134.7,130.1,129.4,127.9,127.6,126.6,126.0,121.1,21.2.
Example 3: 2-p-methoxyphenyl quinazolin-4 (3H) -one
Figure BDA0002849095550000032
O-aminobenzonitrile (1mmol), 4-methoxybenzaldehyde (1.2mmol), CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 96%.
1H NMR(500MHz,DMSO-d6):δ=12.42(br s,1H),8.21(d,J=8.9Hz,2H),8.14(d,J=6.9Hz,1H),7.82(t,J=7.6Hz,1H),7.71(d,J=8.0Hz,1H),7.49(t,J=7.7Hz,1H),7.10(d,J=8.9Hz,2H),3.86(s,3H);13C NMR(125MHz,DMSO-d6):δ=162.5,162.0,152.0,149.1,134.7,129.6,127.5,126.3126.0,125.0,120.9,114.2,55.6.
Example 4: 2- (3, 4-dimethylphenyl) quinazolin-4 (3H) -one
Figure BDA0002849095550000033
O-aminobenzonitrile (1mmol), 3, 4-dimethylbenzaldehyde (1.2mmol) and CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 96%.
1H NMR(500MHz,DMSO-d6)δ=12.36(br s,1H),8.11(d,J=7.9Hz,1H),7.98(s,1H),7.89(d,J=9.3Hz,1H),7.79(t,J=8.3Hz,1H),7.70(d,J=7.9Hz,1H),7.47(t,J=7.9Hz,1H),7.27(d,J=7.9Hz,1H),2.29(s,3H),2.27(s,3H);13C NMR(125MHz,DMSO-d6)δ=162.64,152.72,149.30,140.65,137.01,134.97,130.57,130.11,129.04,127.82,126.75,126.26,125.59,121.33,19.82,19.80.
Example 5: 2-p-fluorophenyl quinazolin-4 (3H) -one
Figure BDA0002849095550000041
Anthranilic acid nitrile (1mmol), 4-fluorobenzaldehyde (1.2mmol) and CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 84%.
1H NMR(500MHz,DMSO-d6):δ=12.58(br s,1H),8.32–8.21(m,2H),8.16(d,J=7.8Hz,1H),7.85(t,J=7.4Hz,1H),7.74(d,J=8.0Hz,1H),7.53(t,J=7.3Hz,1H),7.40(t,J=8.5Hz,2H);13C NMR(125MHz,DMSO-d6):δ=164.2(d,J=249.4Hz),162.4,151.6,148.8,134.8,130.5(d,J=7.7Hz),129.4,127.6,126.8,126.0,121.0,115.8(d,J=21.9Hz).
Example 6: 2- (4-chlorophenyl) quinazolin-4 (3H) -one
Figure BDA0002849095550000042
Anthranilic acid nitrile (1mmol), 4-chlorobenzaldehyde (1.2mmol), CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 86%.
1H NMR(500MHz,DMSO-d6):δ=12.62(br s,1H),8.28–8.10(m,3H),7.85(d,J=6.9Hz,1H),7.75(d,J=7.6Hz,1H),7.63(d,J=7.7Hz,2H),7.54(t,J=6.7Hz,1H);13C NMR(125MHz,DMSO-d6):δ=162.3,151.5,148.8,136.5,134.8,131.7,129.8,128.9,127.7,127.0,126.0,121.2.
Example 7: 2-P-trifluoromethylphenylquinazolin-4 (3H) -one
Figure BDA0002849095550000051
Anthranilic acid nitrile (1mmol), 4-trifluoromethylbenzaldehyde (1.2mmol), CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then diluted and extracted by ethyl acetate, washed by water for three times, and then the organic phase is separated and anhydrousDrying the magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; separating by column chromatography to obtain pure product with yield of 78%
1H NMR(500MHz,DMSO-d6):δ=12.75(br s,1H),8.38(d,J=7.1Hz,2H),8.19(d,J=7.0Hz,1H),7.90(m,3H),7.79(d,J=7.3Hz,1H),7.57(s,1H);13C NMR(125MHz,DMSO-d6):δ=162.5,151.6,148.9,137.1,135.1,131.7(q,JC-F=31.7),129.2,128.1,127.6,126.3,125.9(q,JC-F=3.2Hz),124.4(q,JC-F=271.5Hz),121.7.
Example 8: 2-methylthiophenylquinazolin-4 (3H) -one
Figure BDA0002849095550000052
O-aminobenzonitrile (1mmol), 4-methylthiobenzaldehyde (1.2mmol), CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; separating by column chromatography to obtain pure product with yield of 78%
1H NMR(500MHz,DMSO-d6)δ=12.44(s,1H),8.18–8.04(m,3H),7.78(t,J=7.6Hz,1H),7.68(d,J=8.0Hz,1H),7.46(t,J=7.5Hz,1H),7.35(d,J=8.5Hz,2H),2.51(s,3H);13C NMR(125MHz,DMSO-d6)δ=162.41,151.95,148.98,143.21,134.73,128.83,128.23,127.56,126.54,126.02,125.28,121.07,14.27.
Example 9: 2-styryl-quinazolin-4 (3H) -ones
Figure BDA0002849095550000053
Anthranilic acid nitrile (1mmol), cinnamic aldehyde (1.2mmol), CuCl2(10 mol%) and 1, 10-phenanthroline (1)0mol%),Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 80%.
1H NMR(500MHz,DMSO-d6):δ=12.34(br s,1H),8.12(d,J=7.7Hz,1H),7.96(d,J=16.2Hz,1H),7.82(t,J=7.4Hz,1H),7.68(t,J=7.7Hz,3H),7.50-7.42(m,4H),7.02(d,J=16.2Hz,1H);13C NMR(125MHz,DMSO-d6):δ=161.9,151.6,149.2,138.4,135.2,134.7,130.0,129.3,127.8,127.3,126.4,126.0,121.3.
Example 10: 2- (2-thienyl) quinazolin-4 (3H) -ones
Figure BDA0002849095550000061
Anthranilic acid nitrile (1mmol), 2-thiophenecarboxaldehyde (1.2mmol) and CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 82%.
1H NMR(500MHz,DMSO-d6):δ=12.66(br s,1H),8.25(d,J=4.6Hz,1H),8.14(d,J=7.9Hz,1H),7.88(d,J=5.0Hz,1H),7.81(t,J=7.7Hz,1H),7.67(d,J=8.0Hz,1H),7.50(t,J=7.9Hz,1H),7.27–7.23(m,1H);13C NMR(125MHz,DMSO-d6):δ=162.0,148.8,148.0,137.5,134.9,132.3,129.6,128.7,127.1,126.5,126.2,121.1
Example 11: 2-Benzylquinazolin-4 (3H) -ones
Figure BDA0002849095550000062
Anthranilic acid nitrile (1mmol), phenylacetaldehyde (1.2mmol) and CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 74 percent.
1H NMR(500MHz,DMSO-d6):δ=12.41(br s,1H),8.08(d,J=7.8Hz,1H),7.78(t,J=7.7Hz,1H),7.61(d,J=8.1Hz,1H),7.47(t,J=7.5Hz,1H),7.38(d,J=7.4Hz,2H),7.32(t,J=7.5Hz,2H),7.24(t,J=7.3Hz,1H),3.94(s,2H);13C NMR(125MHz,DMSO-d6):δ=162.0,156.1,149.1,136.7,134.6,129.0,128.7,127.1,127.0,126.4,125.9,120.9,41.0.
Example 12: 2- (1-naphthyl) quinazolin-4 (3H) -one
Figure BDA0002849095550000071
Anthranilic acid nitrile (1mmol), 1-naphthaldehyde (1.2mmol) and CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 74 percent.
1H NMR(500MHz,DMSO-d6):δ=12.67(br s,1H),8.23(d,J=7.8Hz,1H),8.18(d,J=7.7Hz,1H),8.13(d,J=8.2Hz,1H),8.05(d,J=8.4Hz,1H),7.87(t,J=7.6Hz,1H),7.80(d,J=7.0Hz,1H),7.74(d,J=8.1Hz,1H),7.65(t,J=7.7Hz,1H),7.57-7.62(m,3H);13C NMR(125MHz,DMSO-d6):δ=162.1,153.9,148.9,134.7,133.3,131.9,130.6,130.4,128.5,127.9,127.7,127.3,127.0,126.5,126.0,125.4,125.2,121.4.
Example 13: 2-propylquinazolin-4 (3H) -ones
Figure BDA0002849095550000072
Anthranilic acid nitrile (1mmol), n-butyraldehyde (1.2mmol) and CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 70%.
1H NMR(500MHz,DMSO-d6):δ=12.16(br s,1H),8.08(d,J=7.8Hz,1H),7.80–7.74(m,1H),7.59(d,J=8.1Hz,1H),7.46(t,J=7.5Hz,1H),2.58(t,J=7.5Hz,2H),1.79–1.71(m,2H),0.94(t,J=7.4Hz,3H);13C NMR(125MHz,DMSO-d6):δ=162.0,157.5,149.1,134.4,127.0,126.1,125.8,121.0,36.5,20.4,13.7
Example 14: 6-methoxy-2-phenylquinazolin-4 (3H) -one
Figure BDA0002849095550000073
2-amino-5-methoxybenzonitrile (148mg,1mmol), benzaldehyde (1.2mmol), CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 82%.
1H NMR(500MHz,DMSO-d6);δ=12.52(br s,1H),8.17(d,J=7.0Hz,2H),7.71(d,J=8.9Hz,1H),7.59–7.52(m,4H),7.45(dd,J=8.9,2.8Hz,1H),3.90(s,3H);13C NMR(125MHz,DMSO-d6):δ=162.2,157.9,150.3,143.4,133.0,131.2,129.4,128.8,127.7,124.3,122.0,106.1,55.8.
Example 15: 6-methyl-2-phenylquinazolin-4 (3H) -one
Figure BDA0002849095550000081
2-amino-5-methylbenzonitrile (132mg,1mmol), benzaldehyde (1.2mmol), CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 84%.
1H NMR(500MHz,DMSO-d6)δ=12.42(s,1H),8.12(d,J=7.0Hz,2H),7.91(s,1H),7.64–7.59(m,2H),7.55–7.47(m,3H),2.41(s,3H);13C NMR(125MHz,DMSO-d6)δ=162.31,151.63,146.93,136.45,136.02,132.97,131.38,128.74,127.80,127.55,125.41,120.91,21.01.
Example 16: 5-chloro-2-phenylquinazolin-4 (3H) -one
Figure BDA0002849095550000082
2-amino-6-chlorobenzonitrile (152mg,1mmol), benzaldehyde (1.2mmol), CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; layer of warp columnThe pure product can be obtained after separation, and the yield is 76%.
1H NMR(500MHz,DMSO-d6)δ=12.48(s,1H),8.13(d,J=7.4Hz,2H),7.69(t,J=7.9Hz,1H),7.63(d,J=8.0Hz,1H),7.55(d,J=6.9Hz,1H),7.50(t,J=7.3Hz,2H),7.46(d,J=7.4Hz,1H);13C NMR(125MHz,DMSO-d6)δ=160.53,153.15,151.46,134.50,132.68,132.30,131.84,129.09,128.77,128.01,128.01,127.26,118.12.
Example 17: 6-chloro-2-phenylquinazolin-4 (3H) -one
Figure BDA0002849095550000083
2-amino-5-chlorobenzonitrile (152mg,1mmol), benzaldehyde (1.2mmol), CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 75%.
1H NMR(500MHz,DMSO-d6):δ=12.71(br s,1H),8.18(d,J=6.4Hz,2H),8.09(s,1H),7.86(d,J=7.5Hz,1H),7.77(d,J=8.2Hz,1H),7.64-7.52(m,3H);13C NMR(125MHz,DMSO-d6):δ=161.5,153.0,147.7,134.9,132.6,131.8,130.9,129.9,128.8,128.0,125.1,122.4.
Example 18: 6-bromo-2-phenylquinazolin-4 (3H) -one
Figure BDA0002849095550000091
2-amino-5-bromobenzonitrile (197mg,1mmol), benzaldehyde (1.2mmol), CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water were sequentially added to a 25mL reaction tube, and the mixture was reacted at 80 ℃ for 12 hoursCooling to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 78%.
1H NMR(500MHz,DMSO-d6):δ=12.74(br s,1H),8.23(s,1H),8.18(d,J=7.4Hz,2H),7.98(d,J=10.0Hz,1H),7.70(d,J=8.6Hz,1H),7.64–7.50(m,3H);13C NMR(125MHz,DMSO-d6):δ=161.4,153.1,147.9,137.6,132.6,131.8,130.0,128.8,128.2,128.0,122.8,119.1.
Example 19: 6-nitro-2-phenylquinazolin-4 (3H) -ones
Figure BDA0002849095550000092
2-amino-5-nitrobenzonitrile (163mg,1mmol), benzyl alcohol (108mg, 1mmol), Fe (NO)3)3·9H2O (40.4mg,0.10mmol), TEMPO (15.6mg,0.10mmol), t-BuOK (224mg,2equiv) and toluene 2mL were added to a 25mL reaction tube in that order, the mixture was reacted at reflux for 12h, cooled to room temperature; adding ethyl acetate to dilute the reaction solution, washing with water for three times, separating an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 65%.
Comparative example 1
The copper salt in this comparative example was copper nitrate and the procedure was otherwise the same as in example 1.
Anthranilic acid nitrile (1mmol), benzaldehyde (1.2mmol), Cu (NO)3)2(10 mol%) and 1, 10-phenanthroline (10 mol%), Cs2CO3(1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at the temperature of 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 40%.
Comparative example 2
The base in this comparative example was KOH and the procedure was otherwise the same as in example 1.
Anthranilic acid nitrile (1mmol), benzaldehyde (1.2mmol), CuCl2(10 mol%) and 1, 10-phenanthroline (10 mol%), KOH (1equiv) and 2mL of water are sequentially added into a 25mL reaction tube, the mixture reacts for 12h at 80 ℃, and the mixture is cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 60%.
Comparative example 3
The ligand in this comparative example was 2,2' -bipyridine, and the other operations were the same as in example 1.
Anthranilic acid nitrile (1mmol), benzaldehyde (1.2mmol), CuCl2(10 mol%) and 2,2' -bipyridine (10 mol%), KOH (1equiv) and 2mL of water were sequentially added to a 25mL reaction tube, and the mixture was reacted at 80 ℃ for 12 hours and cooled to room temperature; then dilute extracting with ethyl acetate, washing with water for three times, separating out an organic phase, drying with anhydrous magnesium sulfate, and carrying out reduced pressure rotary evaporation to remove the solvent to obtain a crude product; the pure product can be obtained by column chromatography separation, and the yield is 36%.

Claims (10)

1. A preparation method of quinazolinone derivatives is characterized by comprising the following steps:
dissolving the o-aminobenzonitrile compounds shown in the formula I and aldehydes shown in the formula II in a solvent, and heating to react under the combined action of a catalyst, a ligand and alkali to generate quinazoline-4 (3) shown in the formula IIIH) A ketone derivative, after the reaction is finished, quinazoline-4 (3) is obtained by separationH) A crude product of the ketone derivative, which is purified to obtain quinazoline-4 (3)H) -pure ketone derivative;
Figure DEST_PATH_IMAGE002
wherein R is1Is hydrogen, methyl, methoxy, halogen or nitro; r2Is C3-C8Alkyl, benzyl, phenyl,Methylphenyl, methoxyphenyl, halophenyl, trifluoromethylphenyl, nitrophenyl, mercaptophenyl, cinnamyl, naphthyl, thienyl, furyl or pyridyl;
the catalyst is CuXnWherein X is Cl, Br, I, OAc, OTf or SO4And n is 1 or 2.
2. The process for producing a quinazolinone derivative according to claim 1, wherein: the catalyst is CuCl2
3. The process for producing a quinazolinone derivative according to claim 1, wherein: the ligand is one or more than two of 2,2' -bipyridyl, 4' -dimethyl-2, 2' -bipyridyl, triphenylphosphine, tricyclohexylphosphine, triphenylphosphine, 2, 9-dimethyl-1, 10-phenanthroline or 1, 10-phenanthroline.
4. The process for producing a quinazolinone derivative according to claim 3, wherein: the ligand is 1, 10-phenanthroline.
5. The process for producing a quinazolinone derivative according to claim 1, wherein: the alkali is one or more of potassium hydroxide, sodium hydroxide, potassium tert-butoxide, potassium methoxide, sodium bicarbonate, potassium carbonate or cesium carbonate.
6. The method for preparing a quinazolinone derivative according to claim 5, wherein: the base is cesium carbonate.
7. The process for producing a quinazolinone derivative according to claim 1, wherein: the solvent is one or more than two of toluene, dimethyl sulfoxide DMSO, DMF, tert-butanol, water or 1, 4-dioxane.
8. The process for producing a quinazolinone derivative according to claim 7, wherein: the solvent is water.
9. The process for producing a quinazolinone derivative according to claim 1, wherein: the reaction temperature is 60-80 ℃, and the reaction time is 10-12 h; the separation process comprises the steps of cooling the reaction liquid to room temperature, filtering, washing a filter cake and drying; the purification method is column chromatography or recrystallization.
10. The process for producing a quinazolinone derivative according to claim 1, wherein: the molar ratio of the o-aminobenzonitrile compound to the aldehyde to the catalyst to the ligand to the alkali is 1: 1-1.5: 0.08-0.12: 0.8-1.2.
CN202011521464.9A 2020-12-21 2020-12-21 Preparation method of quinazolinone derivative Active CN112645887B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011521464.9A CN112645887B (en) 2020-12-21 2020-12-21 Preparation method of quinazolinone derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011521464.9A CN112645887B (en) 2020-12-21 2020-12-21 Preparation method of quinazolinone derivative

Publications (2)

Publication Number Publication Date
CN112645887A true CN112645887A (en) 2021-04-13
CN112645887B CN112645887B (en) 2023-01-13

Family

ID=75359093

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011521464.9A Active CN112645887B (en) 2020-12-21 2020-12-21 Preparation method of quinazolinone derivative

Country Status (1)

Country Link
CN (1) CN112645887B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110357823A (en) * 2018-04-09 2019-10-22 南京理工大学 The synthetic method of Quinazol derivative
CN113215581A (en) * 2021-04-26 2021-08-06 威海海洋生物医药产业技术研究院有限公司 Carbon steel pickling corrosion inhibitor of quinazoline-4- (3H) -ketone derivative

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101190899A (en) * 2007-12-26 2008-06-04 北京理工大学 Method for synthesizing 1.2-dihydroquinazolin-4(3H)-one compound
CN102584718A (en) * 2011-01-14 2012-07-18 北京理工大学 Method for synthesizing quinazoline-4-(3H)-ketone
CN103435558A (en) * 2013-09-02 2013-12-11 温州大学 Synthetic method of quinazoline derivative
CN104016929A (en) * 2014-06-25 2014-09-03 北京理工大学 Synthesis method of quinazolin-4(3H)-ketone
CN104628643A (en) * 2015-02-17 2015-05-20 大连理工大学 Preparation method of isoquinolone and derivatives thereof
CN106478525A (en) * 2015-08-28 2017-03-08 南京理工大学 A kind of method of synthesis quinazolone
CN106957273A (en) * 2017-03-28 2017-07-18 大连理工大学 A kind of preparation method of quinazolinone and its derivative
CN110357823A (en) * 2018-04-09 2019-10-22 南京理工大学 The synthetic method of Quinazol derivative
CN112608281A (en) * 2020-12-17 2021-04-06 南方医科大学 Green synthesis method and application of quinazolinone compound

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101190899A (en) * 2007-12-26 2008-06-04 北京理工大学 Method for synthesizing 1.2-dihydroquinazolin-4(3H)-one compound
CN102584718A (en) * 2011-01-14 2012-07-18 北京理工大学 Method for synthesizing quinazoline-4-(3H)-ketone
CN103435558A (en) * 2013-09-02 2013-12-11 温州大学 Synthetic method of quinazoline derivative
CN104016929A (en) * 2014-06-25 2014-09-03 北京理工大学 Synthesis method of quinazolin-4(3H)-ketone
CN104628643A (en) * 2015-02-17 2015-05-20 大连理工大学 Preparation method of isoquinolone and derivatives thereof
CN106478525A (en) * 2015-08-28 2017-03-08 南京理工大学 A kind of method of synthesis quinazolone
CN106957273A (en) * 2017-03-28 2017-07-18 大连理工大学 A kind of preparation method of quinazolinone and its derivative
CN110357823A (en) * 2018-04-09 2019-10-22 南京理工大学 The synthetic method of Quinazol derivative
CN112608281A (en) * 2020-12-17 2021-04-06 南方医科大学 Green synthesis method and application of quinazolinone compound

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
PRAVIN N. BORASE,等: "Dihydroquinazolinone based "turn-off" fluorescence sensor for detection of Cu2+ ions", 《DYES AND PIGMENTS》 *
QIXING LIU,等: "Copper-Catalyzed One-Pot Synthesis of 2,3-Dihydroquinazolin-4(1H)-ones from 2-Nitrobenzonitriles and Carbonyl Compounds Mediated by Diboronic Acid in Methanol–Water", 《SYN LETT》 *
SATYANARAYANA BATTULA,等: "Cu–benzotriazole-catalyzed electrophilic cyclization of N-arylimines: a methodical tandem approach to O-protected-4hydroxyquinazolines", 《RSC ADV.》 *
YONGKE HU,等: "Copper-catalyzed tandem oxidative synthesis of quinazolinones from 2-aminobenzonitriles and benzyl alcohols", 《ORG. CHEM. FRONT.》 *
ZIBIN LIU,等: ""On-Water" Synthesis of Quinazolinones and Dihydroquinazolinones Starting from o-Bromobenzonitrile", 《MOLECULES》 *
胡永珂: "醇的需氧氧化反应及其应用研究", 《南京理工大学博士学位论文》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110357823A (en) * 2018-04-09 2019-10-22 南京理工大学 The synthetic method of Quinazol derivative
CN113215581A (en) * 2021-04-26 2021-08-06 威海海洋生物医药产业技术研究院有限公司 Carbon steel pickling corrosion inhibitor of quinazoline-4- (3H) -ketone derivative

Also Published As

Publication number Publication date
CN112645887B (en) 2023-01-13

Similar Documents

Publication Publication Date Title
CN112645887B (en) Preparation method of quinazolinone derivative
CN103435558B (en) Synthetic method of quinazoline derivative
CN108299294A (en) A kind of pleasure is cut down for the preparation method of Buddhist nun's impurity
Chan et al. TMSOTf-catalyzed synthesis of substituted quinazolines using hexamethyldisilazane as a nitrogen source under neat and microwave irradiation conditions
CN107540678B (en) Method for preparing coumarin heteroaromatic ring compound and derivative thereof through intramolecular cross dehydrogenation coupling
JPS58189132A (en) Manufacture of butene derivative
CN106946880A (en) A kind of method for preparing Rui Boxini intermediates
CN104016917B (en) 5,6-dihydro coffee pyridine compounds and preparation method thereof
CN103265545B (en) Method for preparing parazole iso-indole compound
CN105272918B (en) Halogenation -1- alkyl -3- vinyl -2,4,5- triarylimidazoles and preparation method and purposes
CN110117258B (en) Preparation method of 2,4, 6-triaryl substituted pyrimidine compound
CN103408559B (en) A kind of fast synthesis method of camptothecin analogues
CN111777564A (en) Method for synthesizing quinazolinone compound through photocatalytic alcohol oxidation in aqueous phase
CN111718301B (en) Synthetic method of quinazolinone derivative
JP7403835B2 (en) Method for producing 2-iodosobenzoic acids
CN108329290B (en) Preparation method of isocoumarin drug intermediate
CN108329289B (en) Synthetic method of isocoumarin drug intermediate
CN108586342A (en) Condensed biaryl azatropylidene -5- ketone compounds and its synthetic method
CN112174877B (en) Preparation method of 2, 4-diaryl-6-trifluoromethylpyridine derivative
WO2005016937A1 (en) A SYNTHETIC METHOD FOR 6-CHLORO-4-HYDROXY-2-METHYL-2H-THIENO (2,3-e)-1,2-THIAZINE1, 1-DIOXIDE-3-CARBOXYLATE
CN108558750B (en) Process for synthesizing 3-nitroquinoline derivative by solvent-free method
CN108558878B (en) Synthesis process of quinoline and derivatives thereof
CN116621802A (en) Method for synthesizing 3, 4-dibenzoisocoumarin and derivatives thereof through palladium-catalyzed cascade cyclization reaction
CN110746278B (en) Nonmetal-catalyzed method for preparing 1, 3-diketone compound based on alkynone
CN105859620A (en) 6-trichloromethyl phenanthridine compound and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20210413

Assignee: Hubei Moco Biotechnology Co.,Ltd.

Assignor: HUAIYIN INSTITUTE OF TECHNOLOGY

Contract record no.: X2024980005312

Denomination of invention: A Preparation Method of Quinazolinone Derivatives

Granted publication date: 20230113

License type: Common License

Record date: 20240507